Science Explorer Back to mapMap
Discussion
Topic · Hematology

Acute Myeloid Leukemia Research

Acute Myeloid Leukemia Research is a research topic within Hematology. Science Explorer counts 51k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, management, and genomic classification of Acute Myeloid Leukemia (AML). It covers topics such as prognostic factors, clonal hematopoiesis, FLT3 mutations, epigenetic landscapes, therapeutic trials, and the role of hematopoietic stem cells in AML.

  • Acute Myeloid Leukemia
  • AML
  • Genomic Classification
  • Myeloid Neoplasms
  • Prognostic Factors
  • Clonal Hematopoiesis
  • FLT3 Mutations
  • Epigenetic Landscapes
  • Therapeutic Trials
  • Hematopoietic Stem Cells
Research works
51k
fractional, since 1950
In the world top 10%
5.2k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+26%
the tick is no change
Largest producer
United States
40% of the 10 largest, 2022-now

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Acute Myeloid Leukemia Research research?

By volume, the United States and China publish the most (3.7k and 2k works in 2022-now).

By volume, 2022-now

  1. 1 United States 3.7k works
  2. 2 China 2k works
  3. 3 Germany 553 works
  4. 4 Italy 507 works
  5. 5 Japan 486 works
  6. 6 Brazil 473 works
  7. 7 India 447 works
  8. 8 France 377 works
  9. 9 United Kingdom 336 works
  10. 10 Spain 312 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 40.4%China: 21.8%Germany: 6.0%Italy: 5.5%6 others listed: 26.3%40%largest
United States3,727 · 40.4%China2,015 · 21.8%Germany553 · 6.0%Italy507 · 5.5%6 others listed2,430 · 26.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Acute Myeloid Leukemia Research research?

By volume in 2022-now, The University of Texas MD Anderson Cancer Center publishes the most Acute Myeloid Leukemia Research research, followed by Harvard University and Chinese Academy of Medical Sciences & Peking Union Medical College.

Who are the leading researchers in Acute Myeloid Leukemia Research?

The most-cited researchers publishing on Acute Myeloid Leukemia Research include Ahmedin Jemal, Eric S. Lander and Mark J. Daly.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Eric S. Lander United States 524k citations
  3. 3 Mark J. Daly United States 403k citations
  4. 4 Stacey L. Gabriel United States 402k citations
  5. 5 Robert John Tibshirani United States 396k citations
  6. 6 Guido Kroemer France 386k citations
  7. 7 Bert Vogelstein United States 373k citations
  8. 8 Steven L. Salzberg United States 372k citations
  9. 9 Gad A. Getz United States 364k citations
  10. 10 Elaine R. Mardis United States 346k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Acute Myeloid Leukemia Research?

The most cited paper in Acute Myeloid Leukemia Research is "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia" (Daniel A. Arber, Attilio Orazi, Robert Paul Hasserjian et al., 2016), with 10,371 citations. Next come "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell" (7,031) and "Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel" (5,972).

Most cited papers
#PaperReleasedCitations
1 The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Daniel A. Arber, Attilio Orazi, Robert Paul Hasserjian et al. · Blood Open access 12 Apr 2016 10,371
2 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Dominique A. Bonnet, John Edgar Dick · Nature Medicine Jul 1997 7,031
3 Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Hartmut Döhner et al. · Blood Open access 28 Nov 2016 5,972
4 Proposals for the Classification of the Acute Leukaemias F rench ‐A merican ‐B ritish (FAB) C o‐operative G roup John M. Bennett, Daniel Catovsky, Marie‐Theregse Daniel et al. · British Journal of Haematology Aug 1976 5,633
5 Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia The Cancer Genome Atlas Research Network · New England Journal of Medicine Open access 2 May 2013 5,244
All 99 most cited papers, with filters and sorting

Where is Acute Myeloid Leukemia Research research done?

The largest centres of Acute Myeloid Leukemia Research research in 2022-now are Houston (United States), Beijing (China), New York (United States) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Duarte and Lancaster.

Largest cities, 2022-now

  1. 1 HoustonUnited States 393 works
  2. 2 BeijingChina 311 works
  3. 3 New YorkUnited States 201 works
  4. 4 ParisFrance 157 works
  5. 5 São PauloBrazil 150 works
  6. 6 BostonUnited States 149 works
  7. 7 ShanghaiChina 147 works
  8. 8 TokyoJapan 140 works
  9. 9 GuangzhouChina 135 works
  10. 10 HangzhouChina 120 works

Where it is the local speciality

  1. DuarteUS · 24.8 works39×
  2. LancasterUS · 29.3 works32×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Acute Myeloid Leukemia Research than the world average.

See Acute Myeloid Leukemia Research on the map

Where is the best place to study Acute Myeloid Leukemia Research?

Among universities, judged by research, Harvard University, Albert Einstein College of Medicine and Kettering University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.58%fractional works in this field (log) →share of work in the world top 10% →Kettering UniversityHarvard UniversityAlbert Einstein Coll…University of Miami
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 78.721.0%5.2×169 +2.8%
2Albert Einstein College of MedicineUnited States 67.720.3%15.7×55 +136.5%
3Kettering UniversityUnited States 67.428.2%34.2×13 +516.5%
4University of MiamiUnited States 64.720.0%7.3×46 +68.5%
5Vanderbilt UniversityUnited States 60.020.0%4.9×36 +31.2%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 59.47.6%14.3×154 +71.5%
7Heidelberg UniversityGermany 59.217.7%5.6×44 -3.0%
8University of PennsylvaniaUnited States 58.415.1%4.1×44 +32.2%
9Peking UniversityChina 58.110.1%4.7×98 +23.6%
10University of TorontoCanada 57.615.8%2.5×53 +10.5%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Acute Myeloid Leukemia Research, country by country

Is Acute Myeloid Leukemia Research research growing?

Output in 2022-2025 was 26% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Acute Myeloid Leukemia Research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Acute Myeloid Leukemia Research as a percentage of every work published that year, 0.044% in 2024.

still counting0.025%0.050%0.075%Acute Myeloid Leukemia Research0.051% in 202519801990200020102020

Fractional works of Acute Myeloid Leukemia Research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Acute Myeloid Leukemia Research10.3% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Which institutions lead leukaemia research?

By volume in 2022-now, The University of Texas MD Anderson Cancer Center publishes the most Acute Myeloid Leukemia Research research, followed by Harvard University and Chinese Academy of Medical Sciences & Peking Union Medical College.

Which institutions lead Acute Myeloid Leukemia Research research?
All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Acute Myeloid Leukemia Research. Posts are plain text and can be reported.